Healthconn Corp.(TW:6665)
NT$15.600.00 (0.00%)
TW:6665
Healthconn Corp. financials statements
NT$15.60
At close:0.00 (0.00%)
Healthconn Corp. (6665) Ratios
Healthconn Corp. Ratios
TW:6665's free cash flow for Q2 2026 was NT$-128.31M. For the 2026 fiscal year, TW:6665's free cash flow was decreased by NT$-99.93M and operating cash flow was NT$-28.39M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.78 | 2.30 | 2.23 | 2.15 | 2.00 |
| Quick Ratio | 1.38 | 2.04 | 2.04 | 1.85 | 1.84 |
| Cash Ratio | 0.61 | 0.77 | 1.22 | 1.23 | 1.16 |
| Solvency Ratio | 0.10 | 0.14 | 0.11 | 0.12 | 0.13 |
| Operating Cash Flow Ratio | 0.14 | 0.04 | 0.12 | 0.27 | 0.12 |
| Short-Term Operating Cash Flow Coverage | 0.37 | 0.09 | 0.25 | 0.76 | 0.24 |
| Net Current Asset Value | NT$ 300.68M | NT$ 526.33M | NT$ 562.24M | NT$ 623.19M | NT$ 599.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.20 | 0.24 | 0.21 | 0.29 |
| Debt-to-Equity Ratio | 0.30 | 0.32 | 0.40 | 0.37 | 0.55 |
| Debt-to-Capital Ratio | 0.23 | 0.24 | 0.28 | 0.27 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.61 | 1.61 | 1.68 | 1.77 | 1.92 |
| Debt Service Coverage Ratio | 0.24 | 0.43 | 0.28 | 0.35 | 0.28 |
| Interest Coverage Ratio | 0.63 | 2.13 | 0.47 | 10.06 | 9.61 |
| Debt to Market Cap | 0.20 | 0.23 | 0.19 | 0.14 | 0.16 |
| Interest Debt Per Share | 6.37 | 6.88 | 8.17 | 7.83 | 11.41 |
| Net Debt to EBITDA | -0.38 | -0.67 | -3.30 | -3.41 | -2.59 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.03% | 19.06% | 19.54% | 19.63% | 22.51% |
| EBIT Margin | 0.29% | 2.51% | 1.81% | 3.94% | 3.84% |
| EBITDA Margin | 4.65% | 7.20% | 6.88% | 7.96% | 9.37% |
| Operating Profit Margin | 0.29% | 0.98% | 0.23% | 3.94% | 3.83% |
| Pretax Profit Margin | 1.43% | 2.05% | 1.30% | 4.55% | 4.93% |
| Net Profit Margin | 0.74% | 1.53% | 0.19% | 1.65% | 2.75% |
| Continuous Operations Profit Margin | 0.74% | 1.53% | 0.19% | 1.65% | 2.75% |
| Net Income Per EBT | 51.76% | 74.76% | 14.39% | 36.20% | 55.73% |
| EBT Per EBIT | 488.79% | 209.93% | 555.08% | 115.48% | 128.54% |
| Return on Assets (ROA) | 0.56% | 1.26% | 0.15% | 1.53% | 2.11% |
| Return on Equity (ROE) | 0.91% | 2.03% | 0.26% | 2.70% | 4.06% |
| Return on Capital Employed (ROCE) | 0.33% | 1.17% | 0.29% | 5.86% | 4.99% |
| Return on Invested Capital (ROIC) | 0.14% | 0.73% | 0.03% | 1.70% | 2.03% |
| Return on Tangible Assets | 0.57% | 1.28% | 0.16% | 1.55% | 2.15% |
| Earnings Yield | 0.95% | 2.30% | 0.18% | 1.61% | 1.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.18 | 3.92 | 4.63 | 5.25 | 3.45 |
| Payables Turnover | 4.88 | 6.36 | 7.63 | 5.94 | 6.08 |
| Inventory Turnover | 4.85 | 8.06 | 10.34 | 6.69 | 9.28 |
| Fixed Asset Turnover | 6.61 | 6.60 | 6.57 | 7.11 | 6.61 |
| Asset Turnover | 0.76 | 0.82 | 0.82 | 0.93 | 0.77 |
| Working Capital Turnover Ratio | 2.26 | 1.97 | 1.83 | 2.14 | 1.79 |
| Cash Conversion Cycle | 87.89 | 81.04 | 66.35 | 62.71 | 84.95 |
| Days of Sales Outstanding | 87.42 | 93.15 | 78.84 | 69.58 | 105.66 |
| Days of Inventory Outstanding | 75.23 | 45.29 | 35.32 | 54.56 | 39.32 |
| Days of Payables Outstanding | 74.77 | 57.40 | 47.81 | 61.43 | 60.03 |
| Operating Cycle | 162.65 | 138.44 | 114.16 | 124.14 | 144.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.51 | 0.38 | 1.39 | 3.68 | 1.90 |
| Free Cash Flow Per Share | 0.98 | -0.07 | 1.06 | 2.14 | 0.23 |
| Dividend Paid and CapEx Coverage Ratio | 1.20 | 0.76 | 1.78 | 1.64 | 0.48 |
| Capital Expenditure Coverage Ratio | 2.82 | 0.85 | 4.27 | 2.38 | 1.14 |
| Operating Cash Flow Coverage Ratio | 0.24 | 0.06 | 0.17 | 0.48 | 0.17 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.01 | 0.05 | 0.11 | 0.06 |
| Free Cash Flow Yield | 4.87% | -0.38% | 3.67% | 6.12% | 0.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 105.53 | 43.81 | 556.73 | 62.41 | 57.95 |
| Price-to-Sales (P/S) Ratio | 0.78 | 0.67 | 1.05 | 1.02 | 1.59 |
| Price-to-Book (P/B) Ratio | 0.96 | 0.88 | 1.43 | 1.68 | 2.35 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.55 | -264.65 | 27.27 | 16.35 | 206.79 |
| Price-to-Operating Cash Flow Ratio | 13.27 | 48.21 | 20.89 | 9.49 | 25.38 |
| Price-to-Earnings Growth (PEG) Ratio | -1.93 | 0.06 | -6.14 | -1.92 | -0.85 |
| Enterprise Value Multiple | 16.47 | 8.57 | 11.89 | 9.46 | 14.39 |
| Enterprise Value | 866.05M | 773.51M | 1.03B | 1.16B | 1.84B |
| EV to EBITDA | 16.47 | 8.57 | 11.89 | 9.46 | 14.39 |
| EV to Sales | 0.77 | 0.62 | 0.82 | 0.75 | 1.35 |
| EV to Free Cash Flow | 20.09 | -245.33 | 21.34 | 12.02 | 175.22 |
| EV to Operating Cash Flow | 12.97 | 44.69 | 16.35 | 6.97 | 21.51 |
| Tangible Book Value Per Share | 20.72 | 20.50 | 19.66 | 20.20 | 19.67 |
| Shareholders’ Equity Per Share | 20.96 | 20.90 | 20.21 | 20.80 | 20.46 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.48 | 0.25 | 0.86 | 0.64 | 0.44 |
| Revenue Per Share | 25.60 | 27.64 | 27.69 | 34.11 | 30.24 |
| Net Income Per Share | 0.19 | 0.42 | 0.05 | 0.56 | 0.83 |
| Tax Burden | 0.52 | 0.75 | 0.14 | 0.36 | 0.56 |
| Interest Burden | 4.89 | 0.82 | 0.72 | 1.15 | 1.28 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| SG&A to Revenue | 0.18 | 0.18 | 0.19 | 0.16 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Income Quality | 4.12 | 0.67 | 26.66 | 6.56 | 2.28 |
Currency in TWD
